News | April 21, 2023
Top 20 global biopharma companies report 3.4% fall in market cap in Q1 2023: GlobalData
Bayer reported the highest market capitalization growth of 23.1% during Q1 2023
Bayer reported the highest market capitalization growth of 23.1% during Q1 2023
Several late-stage pipeline products have the potential to address some of these unmet needs
Digitization has unleashed a flood of data that presents a huge opportunity but is also overwhelming clinicians, nurses, and administrators
The data highlight the three drug candidates' potential for clinical development and promising synergistic utilities in new indications
WuXi Bio provided technical services, based on the companies' versatile integrated service platforms, to support various manufacturing and process development activities of these ADC product candidates.
The company had acquired 26,000 equity shares having face value of Rs. 10 each fully paid up of Eqova
Science communication brings behavioural changes
Enabling wireless monitoring In ambulances and homes
To enable company to be future-ready by tapping potential in CDMO space
Bourgoin early development hub broadens offerings for oral solid dose formulations
Subscribe To Our Newsletter & Stay Updated
